1. Home
  2. GLAD vs BWAY Comparison

GLAD vs BWAY Comparison

Compare GLAD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

HOLD

Current Price

$18.20

Market Cap

417.7M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$23.21

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAD
BWAY
Founded
2001
2003
Country
United States
Israel
Employees
65
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.7M
450.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GLAD
BWAY
Price
$18.20
$23.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$22.33
$26.50
AVG Volume (30 Days)
209.7K
81.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
9.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.46
$314.08
Revenue Next Year
$8.40
$23.37
P/E Ratio
$11.70
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$17.91
$7.84
52 Week High
$29.50
$26.63

Technical Indicators

Market Signals
Indicator
GLAD
BWAY
Relative Strength Index (RSI) 34.84 48.74
Support Level N/A $21.93
Resistance Level $21.54 $25.71
Average True Range (ATR) 0.44 1.36
MACD 0.01 -0.15
Stochastic Oscillator 25.74 30.62

Price Performance

Historical Comparison
GLAD
BWAY

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: